Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Prostate Cancer Patients on Hormone Therapy: A Sequential Target Trial Emulation Study Proceeding/Conference:ESMO Congress 2025 (17/10/2025-21/10/2025, Berlin)	Shi, RuofanZhan, YongleMa, RuochenAli, SalidaYao, ChiChun, Tsun Tsun StaciaNg, Ada Tsui-LinChiu, Matthew Kin-liangLi, Bryan Cho WingNa, Rong	21-Oct-2025
	Epstein-Barr virus lncBARTs interact with BRD4 and CTCF complex to regulate EBV latent replication and promote EBV-associated oncogenesis Proceeding/Conference:Cancer Research	Liu, JiayanDai, WeiChen, Honglin	21-Apr-2025
	Conversion Therapy Using Catheter-Based Intraperitoneal Chemotherapy for Gastric Cancer with Isolated Peritoneal Metastases: Survival Analysis (Poster Presentation), 16th International Gastric Cancer Congress (IGCC2025), Amsterdam, the Netherlands, 7 to 10 May 2025 Proceeding/Conference:The 6th International Gastric Cancer Congress (IGCC2025) (07/05/2025-10/05/2025, Amsterdam, the Netherlands)	Chiu, HYWong, IYYTsang, Ka ChunWONG, Lai Yin ClaudiaChan, Wing Lok WendyLAW, Tsz TingCHAN, Kwan KitCHAN, Siu YinKwong, Dora Lai WanLaw, Simon Ying KitWong, Yu Hong Ian	8-May-2025
	EBV Inc-BARTs与转录因子BRD4相互作用调节EBV在鼻咽癌潛伏感染 Proceeding/Conference:肿瘤基因组学和癌症筛查学术会议 (19/06/2024-21/06/2024, Zhongshan)	Liu, JiayanMok, Bobo Wing YeeDai, WeiChen, Honglin	19-Jun-2024
	Functional Characterization of Epstein-Barr Virus encoded Inc-BARTs in Associated Tumors Proceeding/Conference:The International Symposium on EBV & KSHV & Related Agents and Diseases 3rd Joint Meeting (29/06/2024-03/07/2024, Boston)	Liu, JiayanMok, BoboDai, WeiChen, Honglin	30-Jun-2024
	NFE2L2 mutations are predictive and prognostic of treatment outcome in resectable esophageal squmaous cell carcinoma patients (Poster Presentation) Proceeding/Conference:Diseases of the Esophagus	Ko, JMYChen, GLo, AWITao, LLaw, SYKLam, KOKwong, DLWWong, IYHWong, CLYChan, SYChan, KKLaw, TTLeung, AKKWong, CWYDai, WLung, ML	30-Aug-2023
	Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced, unresectable hepatocellular carcinoma (START-FIT using STRIDE): A single-arm, phase II study. Proceeding/Conference:Journal of Clinical Oncology	Chiang, Chi LeungChang, Stephen LamChan, Sik-KwanLee, Ann ShingChiu, Keith Wan HangYeung, Vanessa Ting YanWong, Natalie Sean ManLee, Venus Wan YanLau, Vince Wing HangMan, Nancy KwanKong, Feng-Ming SpringChan, Albert Chi Yan	1-Jun-2023
	Peripheral immunological response to treatment with a novel bifunctional anti-PD-L1/TGFβRII agent in recurrent/metastatic nasopharyngeal carcinoma Proceeding/Conference:ASCO Annual Meeting 2023 (02/06/2023-06/06/2023, , , Chicago, Illinois)	Kam, Ngar WoonLau, Jeffrey Yan HoDai, WeiChiang, Chi LeungChe, Chi MingLee, Victor Ho-FunKwong, Dora Lai Wan	1-Jun-2023
	Abstract 6580: A machine learning-based pipeline and web server ImmuneMirror for neoantigen prediction Proceeding/Conference:AACR Annual Meeting 2023 (14/04/2023-19/04/2023, Orlando)	Dai, WeiChuwdhury, Gulam SarwarGuo, YunshanLiu, Zhonghua	4-Apr-2023
	Abstract 4450: SOX4 promotes tumor development and immune evasion via disruption of zinc homeostasis between nasopharyngeal carcinoma cells and T cells Proceeding/Conference:Cancer Research	Yang, YumaGong, LanqiLuo, JieFang, XiaonaHuang, JiaoBai, LuLiu, QinLiu, BeileiLiu, ShanHuang, JinlinWong, Ching NgarZhang, BaifengZheng, DanyangZhang, YuDai, WeiGuan, Xinyuan	4-Apr-2023
	Abstract 4716: Characterization of 3D genome in nasopharyngeal carcinoma (NPC) Proceeding/Conference:Cancer Research	Chung, Dittman Lai-ShunChow, Larry Ka-YueDai, Wei	4-Apr-2023
	Characterization of double-negative B cells within the NPC microenvironment Proceeding/Conference:AACR Annual Meeting 2023 (14/04/2023-19/04/2023, Orlando)	Chung, Michael KingKam, Ngar WoonDai, Wei	4-Apr-2023
	p63 constrains cancer cell transposable element expressions and viral mimicry response to sustain esophageal cancer development and indicates therapeutic vulnerability Proceeding/Conference:Cancer Research	Yu, Valen ZhuoyouSo, Shan ShanLung, Bryan Chee-ChadWong, Carissa Wing-YanWong, Ian Yu-HongWong, Claudia Lai-YinChan, Desmond Kwan-KitChan, Fion Siu-YinLaw, Betty Tsz-TingLam, Ka-OnLo, Anthony Wing-IpKo, Josephine Mum-YeeDai, WeiLam, Alfred King-YinKwong, Dora Lai-WanLaw, SimonLung, Maria Li	4-Apr-2023
	Modeling cancer cachexia using patient tumor organoid-derived xenografts in esophageal squamous cell carcinoma (Poster Presentation) Proceeding/Conference:Diseases of the Esophagus	Lung, BCCYu, VZWong, IYHWong, CLYChan, DKKChan, FSYLaw, BTTLam, KOKwong, DLWLo, AWILaw, SYKLung, ML	30-Aug-2023
	Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021	Tsoi, HMan, PSTSANG, WCWong, LSChan, WLWChan, SYKhoo, US	2021
	Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021	Lok, JTsoi, HMan, PSChan, WLWChan, SYCheng, CNKhoo, US	2021
	Deep learning to develop transcriptomic model for survival prediction in TCGA patients with hepatocellular carcinoma. Proceeding/Conference:Journal of Clinical Oncology	Yu, HDai, WChiang, CLDu, SZeng, ZCShi, GMZhang, WChan, ACYHu, CKong, FP	2020
	Increased Serum Type I Interferon Level May Predict Outcome in Hepatocellular Carcinoma Patients Treated with Radiotherapy Proceeding/Conference:International Journal of Radiation Oncology, Biology, Physics	Du, SChen, YChiang, CLShi, GZhang, WYang, PHu, YChan, ACWKong, FPZeng, ZC	2020
	Incidence and Predictive Factors of Late Mortality in 1353 Five-year Survivors of Nasopharyngeal Cancer (NPC) Proceeding/Conference:International Journal of Radiation Oncology, Biology, Physics	Chiang, CLCheung, CLChoi, CWFong, KSSing, CWHingley, JPLam, TCLee, VHFAu, KHChow, JCHCheung, YTNgan, KCRWong, ICKLee, WMA	2020
	380MO A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure Proceeding/Conference:Annals of Oncology	Lam, TCTsang, KCChoi, CWLee, VHFLam, KOChiang, CLSo, THChan, WLWNyaw, SFLim, FLau, JOChil, JKong, FPLee, WMA	2020